oxybutynin has been researched along with Breast Neoplasms in 8 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We prospectively investigated the reduced effects of adverse events caused by sustained-release oral morphine and controlled-release oxycodone after rotating to the fentanyl patch in patients with metastatic breast cancer." | 9.16 | [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer]. ( Fujii, S; Ikeda, M; Koike, Y; Kubo, S; Kurebayashi, J; Mizutou, A; Nakashima, K; Nomura, T; Oota, Y; Saitou, W; Seki, M; Shiiki, S; Shimo, T; Sonoo, H; Tanaka, K; Yamamoto, Y; Yamashita, T, 2012) |
| "We prospectively investigated the reduced effects of adverse events caused by sustained-release oral morphine and controlled-release oxycodone after rotating to the fentanyl patch in patients with metastatic breast cancer." | 5.16 | [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer]. ( Fujii, S; Ikeda, M; Koike, Y; Kubo, S; Kurebayashi, J; Mizutou, A; Nakashima, K; Nomura, T; Oota, Y; Saitou, W; Seki, M; Shiiki, S; Shimo, T; Sonoo, H; Tanaka, K; Yamamoto, Y; Yamashita, T, 2012) |
| "Development of an effective breast cancer vaccine can be a groundbreaking immunotherapeutic approach." | 1.51 | Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin. ( Akalkotkar, A; Chablani, L; D'Souza, MJ; Tawde, SA, 2019) |
| "To assess how women in Sweden with breast cancer (BC), endometrial cancer (EC), and/or pulmonary embolism (PE) were dispensed menopausal hormone therapy (HT)." | 1.51 | Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study. ( Fredrikson, M; Hammar, M; Hoffmann, M; Lindh-Åstrand, L; Spetz Holm, AC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gera, R | 1 |
| Tayeh, S | 1 |
| Chehade, HE | 1 |
| Mokbel, K | 1 |
| Chablani, L | 1 |
| Tawde, SA | 1 |
| Akalkotkar, A | 1 |
| D'Souza, MJ | 1 |
| Lindh-Åstrand, L | 1 |
| Hoffmann, M | 1 |
| Fredrikson, M | 1 |
| Hammar, M | 1 |
| Spetz Holm, AC | 1 |
| Garzón-Rodríguez, C | 1 |
| Casals Merchan, M | 1 |
| Calsina-Berna, A | 1 |
| López-Rómboli, E | 1 |
| Porta-Sales, J | 1 |
| Heikkinen, S | 1 |
| Koskenvuo, M | 1 |
| Malila, N | 1 |
| Sarkeala, T | 1 |
| Pukkala, E | 1 |
| Pitkäniemi, J | 1 |
| Li, L | 1 |
| Xu, X | 1 |
| Fang, L | 1 |
| Liu, Y | 1 |
| Sun, Y | 1 |
| Wang, M | 1 |
| Zhao, N | 1 |
| He, Z | 1 |
| Ikeda, M | 1 |
| Sonoo, H | 1 |
| Kurebayashi, J | 1 |
| Oota, Y | 1 |
| Fujii, S | 1 |
| Shimo, T | 1 |
| Mizutou, A | 1 |
| Seki, M | 1 |
| Saitou, W | 1 |
| Yamashita, T | 1 |
| Koike, Y | 1 |
| Yamamoto, Y | 1 |
| Shiiki, S | 1 |
| Nakashima, K | 1 |
| Tanaka, K | 1 |
| Nomura, T | 1 |
| Kubo, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Preventive Application Of Lidocaine Patch In Adjunction To Intravenous Morphine Analgesia For Management Of Post-Thoracotomy Pain: Results Of A Randomized, Double Blind, Placebo Controlled Study[NCT02751619] | 90 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxybutynin and Breast Neoplasms
| Article | Year |
|---|---|
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review.
Topics: Administration, Cutaneous; Breast Neoplasms; Female; Humans; Menopause; Risk Factors; Sexual Dysfunc | 2018 |
2 trials available for oxybutynin and Breast Neoplasms
| Article | Year |
|---|---|
Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.
Topics: Anesthetics, Local; Breast Neoplasms; Cicatrix; Female; Follow-Up Studies; Humans; Lidocaine; Male; | 2013 |
[A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Therapy, Combin | 2012 |
5 other studies available for oxybutynin and Breast Neoplasms
| Article | Year |
|---|---|
Oxybutynin for hot flashes in women with breast cancer.
Topics: Breast Neoplasms; Delayed-Action Preparations; Drug Interactions; Female; Hot Flashes; Humans; Mande | 2019 |
Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin.
Topics: Administration, Cutaneous; Animals; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Cell Line | 2019 |
Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.
Topics: Aged; Breast Neoplasms; Cohort Studies; Contraindications, Drug; Endometrial Neoplasms; Estrogen Rep | 2019 |
Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment.
Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Drug Implants | 2016 |
The transdermal patches for site-specific delivery of letrozole: a new option for breast cancer therapy.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Breast Neoplasms; Female; Letrozole; Mice | 2010 |